Cardinal Health announces organizational changes

Print Friendly, PDF & Email

Debbie Weitzman named CEO of pharmaceutical segment.

DUBLIN, Ohio — Cardinal Health announced on Thursday Debbie Weitzman, current president of Pharmaceutical Distribution, will become CEO of the company’s Pharmaceutical Segment. Weitzman will replace Victor Crawford, who will be stepping down as Pharmaceutical Segment CEO effective September 19, but will remain with the company until November 13 to help with the transition. The role of president of Pharmaceutical Distribution will be eliminated.

Debbie Weitzman

The company has further streamlined the Pharmaceutical Segment by restructuring and eliminating additional roles. As a result of these changes, the Pharmaceutical and Specialty Distribution businesses will both report directly to Debbie Weitzman.

“Debbie has been a tremendous leader at Cardinal Health, and we believe her knowledge and experience make her the right person to lead our redesigned Pharmaceutical Segment,” said Jason Hollar, Chief Executive Officer of Cardinal Health. “I believe this new design will allow us to have added focus on specialty distribution, which is a key growth area for the company, as well as simplify how our customers and manufacturers work with us.”

Hollar added, “On behalf of the Board and entire company, I want to thank Victor for his leadership and many contributions to our business and culture during his time with Cardinal Health. Victor’s steadfast leadership helped our Pharmaceutical Segment navigate the challenging environment during the pandemic, and we’re grateful he will remain with us through November 13 to ensure a smooth transition.”

The moves in the Pharmaceutical Segment come as part of the company’s broader simplification efforts to streamline its organizational structure and are specifically aimed to strengthen the company’s Pharmaceutical and Specialty Distribution, as well as bring together similar services under one team.


Comments are closed.

Adheris Health